Early diagnosis of acute coronary syndrome

Hugo Katus(Heidelberg University), André Ziegler(Roche (Switzerland)), Okan Ekinci(University College Dublin), Evangelos Giannitsis(Heidelberg University), Wendy Gattis Stough(Campbell University), Stephan Achenbach(Friedrich-Alexander-Universität Erlangen-Nürnberg), Stefan Blankenberg(Deutsches Herzzentrum der Charité), Martina Brueckmann(Boehringer Ingelheim (Germany)), Paul Collinson(St George's, University of London), Dorin Comaniciu(Siemens Healthineers (Germany)), Filippo Crea(Università Cattolica del Sacro Cuore), Wilfried Dinh(Helios Universitätsklinikum Wuppertal), Grégory Ducrocq(Hôpital Bichat-Claude-Bernard), Frank A. Flachskampf(Uppsala University), Keith A.A. Fox(Edinburgh Royal Infirmary), Matthias G. Friedrich(Heidelberg University), Kathy Hebert, Anders Himmelmänn(AstraZeneca (Sweden)), Mark A. Hlatky(Stanford University), Dominik Lautsch(Merck & Co., Inc., Rahway, NJ, USA (United States)), Bertil Lindahl(Uppsala University), Daniel Lindholm(Uppsala University), Nicholas L. Mills(University of Edinburgh), Giorgio Minotti(Università Campus Bio-Medico), Martin Möckel(Charité - Universitätsmedizin Berlin), Torbjørn Omland(University of Oslo), Véronique Semjonow(Philips (Netherlands))
European Heart Journal
August 21, 2017
Cited by 62Open Access
Full Text

Abstract

The diagnostic evaluation of acute chest pain has been augmented in recent years by advances in the sensitivity and precision of cardiac troponin assays, new biomarkers, improvements in imaging modalities, and release of new clinical decision algorithms. This progress has enabled physicians to diagnose or rule-out acute myocardial infarction earlier after the initial patient presentation, usually in emergency department settings, which may facilitate prompt initiation of evidence-based treatments, investigation of alternative diagnoses for chest pain, or discharge, and permit better utilization of healthcare resources. A non-trivial proportion of patients fall in an indeterminate category according to rule-out algorithms, and minimal evidence-based guidance exists for the optimal evaluation, monitoring, and treatment of these patients. The Cardiovascular Round Table of the ESC proposes approaches for the optimal application of early strategies in clinical practice to improve patient care following the review of recent advances in the early diagnosis of acute coronary syndrome. The following specific 'indeterminate' patient categories were considered: (i) patients with symptoms and high-sensitivity cardiac troponin <99th percentile; (ii) patients with symptoms and high-sensitivity troponin <99th percentile but above the limit of detection; (iii) patients with symptoms and high-sensitivity troponin >99th percentile but without dynamic change; and (iv) patients with symptoms and high-sensitivity troponin >99th percentile and dynamic change but without coronary plaque rupture/erosion/dissection. Definitive evidence is currently lacking to manage these patients whose early diagnosis is 'indeterminate' and these areas of uncertainty should be assigned a high priority for research.


Related Papers